Semaglutide treatment restored GLP-1 levels, regulated Socs3 expression in ARC and improved leptin sensitivity and the hypothalamic anorexigenic signaling (POMC/MC4R) for obesity control in these obese mice [131]. Here, SOCS3 is linked to obesity disorder.